In swine production units where on-farm feed blending is performed with vertical screw conveyors and horizontal ribbon mixers, Leiwan Binglang Powder Veterinary Grade API is handled as a multicomponent plant powder rather than as a single purified alkaloid. The powder is screened through 80 mesh (180 µm) stainless steel to remove agglomerates, and analytical acceptance requires total alkaloid content of 0.30%–0.65% w/w calculated as arecoline by high-performance liquid chromatography because the seed and pericarp fractions vary with harvest region and drying temperature. A working premix is prepared at 5.0% w/w API on a calcium carbonate and soybean oil carrier, using geometric dilution in 50 kg lots before transfer to a 500 kg horizontal ribbon blender at 60% loading. The blender is operated at 25 rpm for 20 min, and acceptance is based on 10 individual thief samples with relative standard deviation below 5.0% as a blend uniformity control consistent with the sampling principles of ISO 6497:2002. If carrier moisture exceeds 6.0% w/w after mixing, bridging occurs in screw conveyors; the premix is then re-dried with forced air at 40°C and re-mixed for 10 min. Residual solvents are controlled under VICH GL18(R2), elemental impurities under ICH Q3D(R2) where regional requirements apply, and the finished premix is packed at ≤60% relative humidity into three-ply paper bags with a polyethylene liner to prevent hygroscopic caking. Terminal use is a swine oral premix intended for mix-in feed administration, not for direct oral dosing without dilution.

Why Does Alkaline pH Accelerate Arecoline Ester Hydrolysis in Aqueous Veterinary Injectables?

When an injectable solution is required, Leiwan Binglang Powder Veterinary Grade API cannot be directly dissolved because the raw powder contains cellulosic pericarp particles, tannins, and lipid components that would fail Ph. Eur. 2.9.19 particulate contamination after terminal sterilisation. A validated acidic extraction step is therefore introduced before sterile filtration. Arecoline, the principal alkaloid, contains a methyl ester group that undergoes base-catalysed hydrolysis to arecaidine; aqueous stability is acceptable in the range pH 3.5–5.0, while above pH 6.0 degradation accelerates rapidly at ambient temperature. Published data for this specific configuration is limited, and forced degradation studies at pH 3.0, 4.5, 6.0, and 8.0 should be completed before batch release. The manufacturing sequence uses Water for Injections cooled to 20–25°C, acidified with citric acid to pH 4.5, and the API is extracted under nitrogen purging to minimise oxidative browning. The extraction liquor is cooled to 4°C for 8 h to precipitate tannins, then clarified through 1.0 µm and 0.45 µm depth filters. Sterile filtration is performed through a 0.22 µm PVDF membrane, and the final solution is filled into amber Type I glass vials and steam-sterilised at 121°C for 15 min according to Ph. Eur. 5.1.1. Osmolality is adjusted with sodium chloride to 290–310 mOsm/kg using Ph. Eur. 2.2.35. Terminal product is a sterile veterinary injection for parenteral administration under veterinary supervision, not a large-volume infusion.

When 60% ethanol granulation raises tablet hardness below 45 N

Tablet compression of Leiwan Binglang Powder Veterinary Grade API is complicated by fibrous particles and tannin-mediated stickiness at high moisture; direct compression produces capping below 45 N on a 16-station rotary press. Wet granulation with 60% ethanol and 5.0% w/w polyvinylpyrrolidone K30 binder reduces elastic recovery and increases cohesiveness. A representative core composition contains 30.0% w/w API, 38.0% w/w microcrystalline cellulose, 25.5% w/w lactose monohydrate, 3.0% w/w crospovidone, 2.0% w/w PVP K30, 1.0% w/w colloidal silicon dioxide, and 0.5% w/w magnesium stearate. Granulation is carried out in a high-shear mixer at impeller tip speed 5 m/s and chopper 1500 rpm until wet mass moisture reaches 10–12% w/w; the mass is tray-dried at 50°C to loss on drying 1.5–3.0% w/w by Ph. Eur. 2.2.32. Because the API contains residual fixed oil, magnesium stearate is added last after dry blending to avoid overlubrication that lowers tablet hardness. Compression force is maintained at 8–15 kN to target hardness 50–80 N and disintegration below 15 min in 37°C water per USP <701>. Film coating with an aqueous hydroxypropyl methylcellulose system at 3.0% weight gain masks the alkaloid taste and reduces oral mucosal irritation. Terminal product is a veterinary oral tablet for individual animal dosing, with content uniformity verified by USP <905> and dissolution by USP <711> apparatus II at 50 rpm in 0.1 N HCl.

Drinking-Water Oral Solution Stability Under Tropical Storage

For poultry mass administration through drinking water, Leiwan Binglang Powder Veterinary Grade API is processed as a dilute aqueous extract rather than a suspension because settling fibres block nipple drinker lines. Extraction in 80°C water for 60 min recovers water-soluble alkaloid salts; the extraction ratio is 100 g API per 1 L final solution. Water hardness above 200 ppm calcium carbonate can precipitate tannin complexes, so deionised water is used throughout. The extract is cooled to 30°C and preserved with 0.1% w/v sodium metabisulfite and 0.2% w/v sodium benzoate, then adjusted to pH 4.0 with citric acid. Filtration through 5 µm and 1 µm cartridge filters removes colloidal tannin flocculate. Stability under tropical storage at 40°C and 75% relative humidity is evaluated for 6 months according to VICH GL3(R) stability testing for new veterinary drug substances and medicinal products; if all assay values remain within 90.0–110.0% of label claim, the shelf life is accepted. Microbial quality is tested under Ph. Eur. 5.1.4 for non-sterile oral liquids, with total aerobic microbial count not exceeding 10² CFU/mL and Escherichia coli absent in 1 mL. Terminal product is a veterinary drinking-water oral solution packaged in 1 L and 5 L HDPE bottles with tamper-evident caps, protected from direct sunlight to limit photodegradation of arecoline.

Compounding pharmacies that prepare hard-gelatin capsules for companion-animal deworming protocols encounter low bulk density and poor flow from raw plant powder, which causes fill weight variability on dosator-type encapsulators. The formulation approach is dry granulation through slugging on a rotary tablet press at 120 MPa compaction pressure, followed by size reduction to 0.5–1.0 mm granules. A capsule blend containing 40.0% w/w API, 49.0% w/w lactose monohydrate, 7.0% w/w pregelatinised starch, 2.0% w/w sodium starch glycolate, 1.0% w/w talc, and 0.5% w/w magnesium stearate is filled into size 1 hard-gelatin capsules with a target net fill weight of 250 mg. Hygroscopicity of the raw powder at RH >65% causes capsule shell brittleness, so relative humidity during encapsulation is maintained at 40–50%. Weight variation is controlled by USP <905> for capsules, and dissolution is performed using USP <711> apparatus I at 100 rpm in 900 mL of 0.1 N HCl at 37°C. The terminal product is a veterinary capsule for dogs, stored in amber glass or high-barrier polyvinyl chloride/polyvinylidene chloride blister cavities at ≤25°C to prevent gelatin cross-linking from aldehyde contaminants in the plant powder. Published data for this specific configuration is limited; therefore, a batch-specific forced degradation study is required before assigning retest dates.

Low-Dust Granulation Reduces Arecoline Carryover on Shared Premix Lines

Fine plant powder with particle size below 180 µm generates electrostatic dust and high residual carryover in ribbon blenders, particularly in premix lines where subsequent batches of unrelated additives must remain uncontaminated. To address this, the API is converted into multiparticulate granules by fluid-bed top-spray granulation using a 5.0% w/w methylcellulose solution as binder. Process conditions are inlet air 60°C, product bed temperature 38–42°C, spray rate 25 g/min/kg, and atomising air 1.5 bar. The dried granules are screened to 0.5–1.0 mm and have loss on drying ≤3.0% w/w by USP <731>. In a 500 kg horizontal ribbon blender, the granulated premix at 10.0% w/w API is mixed for 15 min at 20 rpm; blade clearance is set at 5–10 mm to reduce heel residue. Final carryover is measured by cleaning validation swab sampling and quantified by HPLC with a limit of not more than 10 ppm of arecoline in the next batch. Terminal product is a granulated oral premix for veterinary feed incorporation, packaged in 20 kg woven polypropylene bags with an inner polyethylene liner and sealed against moisture ingress.